Get 40% Off
💰 Warren Buffett reveals a $6.72 billion stake in ChubbCopy Portfolios

Here's Why You Should Hold On To Stericycle (SRCL) Stock

Published 06/13/2019, 04:17 AM
Updated 07/09/2023, 06:31 AM
US500
-
SRCL
-
NCI_old
-
GPN
-
NVEE
-

Stericycle, Inc.’s (NASDAQ:SRCL) stock has gained 22.4% year to date, outperforming the 14% rally of the Zacks S&P 500 composite.

With an expected long-term earnings per share growth rate of 7.7% and a market cap of $4.1 billion, Stericycle seems to be a stock that investors should retain in their portfolio for now.

Factors That Bode Well

Stericycle is progressing well with its comprehensive multiyear business transformation, aimed at improving long-term operational and financial performance. Initiated in 2017, the five key initiatives of the program include portfolio rationalization, operational optimization, organizational excellence and efficiency, commercial excellence and strategic sourcing.

The company’s main focus for 2019 is to build, test and train phases of enterprise resource planning (ERP) implementation. It has completed the build phase and is currently in the test phase which will be followed by the train phase. The company expects to witness $850 million to $1 billion of adjusted EBITDA benefits over the tenure of the program.

Stericycle’s acquisition pool remains robust in multiple geographies and lines of business, thereby helping it increase its market share and expand geographically.

Last Words

Despite riding on significant growth prospects, Stericycle is not free from overhangs. The company’s communication and related services have been weak for quite some time due to decline in recall events and lower call volumes in communication solutions. It has a debt-laden balance sheet and faces pricing pressure due to high competition. Nevertheless, we believe that the multiyear business transformation initiative and acquisitions bode well in the long term.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks Rank & Key Picks

Currently, Stericycle has a Zacks Rank #3 (Hold).

Some top-ranked stocks in the broader Zacks Business Services sector are Navigant Consulting (NYSE:NCI) , Global Payments (NYSE:GPN) and NV5 Global (NASDAQ:NVEE) . While Navigant Consulting sports a Zacks Rank #1 (Strong Buy), Global Payments and NV5 Global carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Long-term expected EPS (three to five years) growth rate for Navigant Consulting, Global Payments and NV5 Global is 13.5%, 16.9% and 20%, respectively.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1% and +98.3%.

This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.

See their latest picks free >>



NV5 Global, Inc. (NVEE): Free Stock Analysis Report

Navigant Consulting, Inc. (NCI): Free Stock Analysis Report

Global Payments Inc. (GPN): Free Stock Analysis Report

Stericycle, Inc. (SRCL): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.